Events

Antimicrobial resistance is an increasingly serious threat to global public health that requires action across all government sectors and society. BioInfect will look at the critical issues relating to the development of new anti-infectives and the endemic problem of resistance.   Dr. Richard Lawson, CARB-X Senior Project Manager, will be delivering the keynote address.

Kevin Outterson is the N Neal Pike Professor of Health and Disability Law at Boston University and the Executive Director of CARB-X, the world’s largest product development partnership addressing drug-resistant bacterial infections. He will share his personal stories of how experiences, skills, passion and faith converge in the efforts to protect us all from drug-resistant bacterial infections.

The All-Party Parliamentary Group on Antibiotics APPG-A exists to raise the profile of antibiotic resistance, the need to preserve antibiotics through education on their appropriate use including non‐human uses, the lack of new treatments for bacterial infections and to help accelerate efforts to discover, research and develop new treatments. The British Society for Antimicrobial Chemotherapy serves as Secretariat […]

This webinar aims at making a presentation of a recent GARDP co-organized conference session accessible to anyone who didn't have the chance to attend the meeting. After the showing of the recording of her presentation "Making Safety a Part of Drug Design", Claire Sadler will join us online for a live Q&A session. This presentation […]

This event is an invitation-only side event to the 2nd Call to Action on Antimicrobial Resistance hosted by the Access to Medicine Foundation, the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) and the Global Antibiotic Research & Development Partnership (GARDP).  In this session, the Access to Medicine Foundation, CARB-X and GARDP will share how they guide, support and […]